EORTC 22071-24071: Randomized, phase III trial of EGFR-antibody combined with adjuvant chemoradiation for patients with head and neck squamous cell carcinoma (HNSCC) at high risk of recurrence.
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS197-TPS197
◽
2011 ◽
Vol 100
(1)
◽
pp. 70-75
◽
2011 ◽
Vol 18
(1)
◽
pp. 301-307
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5506-5506
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 98
(2)
◽
pp. E33
2015 ◽
Vol 8
(4)
◽
pp. 287-295
◽
Keyword(s):